Drug Shortage Report for CEFAZOLIN FOR INJECTION

Last updated on 2023-07-06 History
Report ID 182608
Drug Identification Number 02437120
Brand name CEFAZOLIN FOR INJECTION
Common or Proper name CEFAZOLIN FOR INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-01-31
Actual start date
Estimated end date 2023-06-30
Actual end date 2023-06-30
Shortage status Resolved
Updated date 2023-07-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-07-06 French Compare
v6 2023-07-06 English Compare
v5 2023-04-25 French Compare
v4 2023-04-25 English Compare
v3 2023-02-01 English Compare
v2 2023-01-27 French Compare
v1 2023-01-27 English Compare

Showing 1 to 7 of 7